Close Menu

NEW YORK – Several investment banks announced they have initiated coverage of Berkeley Lights, the cell screening instrument maker that recently went public. 

JP Morgan, Cowen, and William Blair analysts all are bullish on the stock. JP Morgan analyst Tycho Peterson gave it an "Overweight" rating with a price target of $75; Cowen analyst Doug Schenkel and William Blair analyst Brian Weinstein rated it "Outperform," but did not provide a price target.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.